$78M Series A
$78M Series A
| Investor | Firm Type | Partner |
|---|---|---|
| Private |
| — |
| Venture Capital | — |
AbingworthLEAD | Venture Capital | — |
F Prime CapitalLEAD | Venture Capital | — |
Andrew SinclairLEAD | Angel | Andrew Sinclair |
Chong XuLEAD | Angel | Chong Xu |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$78M
Top Valuation
-
R1 Therapeutics raised $78M in a Series A round.
The round was led by Abingworth, F-Prime Capital, Andrew Sinclair, Chong Xu, DaVita Venture Group, Chong Xu.